Citadel Advisors’s Astrea Acquisition Corp. Class A Common Stock ASAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-299,617
Closed -$2.95M 15796
2022
Q3
$2.95M Buy
299,617
+211
+0.1% +$2.08K ﹤0.01% 4842
2022
Q2
$2.92M Sell
299,406
-2,519
-0.8% -$24.7K ﹤0.01% 4797
2022
Q1
$2.95M Sell
301,925
-4,577
-1% -$44.7K ﹤0.01% 5229
2021
Q4
$3.03M Buy
306,502
+5,985
+2% +$59.2K ﹤0.01% 5315
2021
Q3
$3M Buy
300,517
+1,274
+0.4% +$12.4K ﹤0.01% 5366
2021
Q2
$2.89M Buy
299,243
+362
+0.1% +$3.52K ﹤0.01% 5694
2021
Q1
$2.88M Buy
+298,881
New +$2.89M ﹤0.01% 5539

Citadel Advisors's ASAX Position: Q4 2022 in Review

Citadel Advisors sold out of Astrea Acquisition Corp. Class A Common Stock (ASAX) in Q4 2022, closing a stake of 299,617 shares — an estimated $2.95M sold.

Citadel Advisors first reported a position in ASAX in Q1 2021 and held it in 7 quarters. The position peaked at $3.03M in Q4 2021. 0 funds tracked by Wall St. Rank hold ASAX as of Q4 2022.

  • Citadel Advisors reported no remaining Astrea Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Citadel Advisors sold 299,617 Astrea Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $2.95M.
  • Citadel Advisors first reported a position in Astrea Acquisition Corp. Class A Common Stock in Q1 2021 and held it in 7 quarters.
  • Citadel Advisors's Astrea Acquisition Corp. Class A Common Stock position peaked at $3.03M in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Astrea Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.